Parakeet Health is an AI-driven patient engagement and access platform that replaces manual medical-office workflows — appointment scheduling, referral intake, cancellations, and FAQs — with autonomous conversational AI across voice, SMS, fax and email, integrated to EHR and practice-management systems. Jung Park (HMC undergrad; 20 years healthcare operations — VP One Medical, GM Epocrates, business leader at specialty practices) paired with Eric Mao and Aaron Lee (Berkeley; technical) to build the voice-agent product. The wedge is that Parakeet has real EHR integrations and appointment-conversion metrics, not just a call-center wrapper.
AI voice agents in healthcare estimated at $472M in 2025 growing to $3.2B by 2030 at 37.8% CAGR (Web). The broader AI patient-engagement market is projected to reach $24.74B by 2030 at 21.7% CAGR (Web). Parakeet closed $3M seed at $15M post with Canvas Ventures leading in March 2024 (Internal). By January 2025 the business had ~$800K ARR, $1M contracts in pipeline, and $2.4M cash at $80-100K/mo burn (Internal). Canvas led the Series A in March 2026 at $50M post ($7M new money, additional pro rata from Runa and Fund I), giving StoryHouse a substantial mark-up. Sword Health (~$3B late-stage) approached Parakeet for potential acquisition in early 2025.
Two overlapping high-growth categories. The specific "AI voice for medical practices" surface Parakeet owns is roughly 37.8% CAGR from a $472M base, and the ROI to clinics (higher appointment conversion, lower admin cost) is easy to measure.
| Player | Positioning | Funding / Stage | Edge vs. them |
|---|---|---|---|
| Parakeet Health | AI voice + SMS/fax/email patient engagement with EHR integrations | Series A closed 2026 at $50M post | — |
| Hyro | Conversational AI for healthcare (voice + chat) | Series B ($20M+) | Parakeet claims deeper EHR/PMS integration and multi-channel (voice/SMS/fax/email). |
| Notable Health | AI patient engagement + intake | Series C | Notable is broader/enterprise; Parakeet targets specialty and mid-market practices with faster time-to-value. |
| Assort Health | AI voice for healthcare call centers | Series A | Direct competitor; Parakeet's multi-channel differentiation. |
| Curai Health | AI clinical + engagement | Series C | Curai is clinician-facing; Parakeet is patient-facing. |
Moat: EHR / practice-management integrations at the depth needed to convert appointments (not just triage), plus Jung's operator relationships inside specialty practices as a distribution channel.
Sword Health's approach in Jan 2025 establishes a real strategic buyer path even at seed stage. With the Series A at $50M post, StoryHouse's entry at $15M is already ~3.3x on paper before any real exit outcome.
Sword Health (~$3B late-stage) approached Parakeet for acquisition as part of a spin-off AI initiative; two radiology contracts closed; $800K ARR; $1M pipeline; $2.4M cash with $80-100K/mo burn.
RAW NOTES: Sword Health - MSK Physical Therapy Juggernaut; $3B late-stage company. They are announcing the spin-off of an AI initiative. Their Board and CEO have committed to an AI-solution. As part of that, they have reached out to Parakeet for an acquisition in addition to one other company. Business is going well: Two radiology contracts - Genome Medical, 20K, another for $134K, another for $126K; about $800K in ARR. Have some $1M contracts in pipeline. $2.4M cash, burning 80-100K per month. Headcount: Two engineers (Jung + engineer). One Commission only sales. Encouraged Jung not to spend time on the acquisition discussion.
Portfolio check-in after seed close.
RAW NOTES: Portfolio checkpoint post-seed close.
Reference from Sharvil: liked the idea, agreed with earlier concern that clinic integration is very difficult; recommended diligence on integration model and complex-billing edge cases.
Feedback from Sharvil re: Parakeet. I actually like this idea a lot. I agree with Clay that there is a lot of competition and I think that integrating into practices is going to be super difficult. I would diligence around their integration model and how they handle edge cases (eg complex billing questions). If I was writing an angel check, I would diligence the team's ability to understand how a clinic runs and how they integrate with it + how they think about their sales cycle + product strategy more broadly. Happy to talk to them if that'd be helpful.
Sharvil: "I actually like this idea a lot. I agree with Clay that there is a lot of competition and I think that integrating into practices is going to be super difficult. I would diligence around their integration model and how they handle edge cases."
Source: Meeting Notes rec3xvjDDx3DLSrRB · 2024-02-27
Reference call with Jung Park confirmed 20-year healthcare operations background including One Medical VP and Epocrates GM.
Source: Meeting Notes recmXEi3tiqtMUnn3 · 2024-01-16